Chimeric Therapeutics Limited

Chimeric Therapeutics Limitedverified

CHMMF

Price:

$0.001

Market Cap:

$10.93M

Chimeric Therapeutics Limited, a clinical stage cell therapy company, develops and commercializes a range of cell therapies in oncology in Australia. The company develops CHM 0201 (core NK platform) that is in phase I clinical trial for treating solid tumors and hematological malignancies; and CHM 1101 (CLTX CAR T), which is in phase I clinical trial for treating patients with MMP2+ recurrent or progressive glioblastoma. It is also developing CHM 0301 for blood cancers; CHM 1301 (CLTX CAR NK) and CHM 2301 (CDH17 CAR NK) for solid tumors; CHM 1101 (CLTX CAR T) for melanoma, colorectal, and prostate; and CHM 2101 (CDH17 CAR T) for neuroendocrine, colorectal, pancreatic, and gastric. The compan...[Read more]

Industry

Biotechnology

IPO Date

2022-11-30

Stock Exchange

OTC

Ticker

CHMMF

The Enterprise Value as of December 2025 (TTM) for Chimeric Therapeutics Limited (CHMMF) is 5.17M

According to Chimeric Therapeutics Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 5.17M. This represents a change of -34.93% compared to the average of 7.94M of the last 4 quarters.

Chimeric Therapeutics Limited (CHMMF) Historical Enterprise Value (quarterly & annually)

How has CHMMF Enterprise Value performed in the past?

The mean historical Enterprise Value of Chimeric Therapeutics Limited over the last ten years is 34.11M. The current 5.17M Enterprise Value has changed 1.42% with respect to the historical average. Over the past ten years (40 quarters), CHMMF's Enterprise Value was at its highest in in the December 2020 quarter at 102.31M. The Enterprise Value was at its lowest in in the June 2023 quarter at -1722293.06.

Quarterly (TTM)
Annual

Average

34.11M

Median

13.90M

Minimum

-349606.73

Maximum

97.54M

Chimeric Therapeutics Limited (CHMMF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Chimeric Therapeutics Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 17.76%

Maximum Annual Enterprise Value = 97.54M

Minimum Annual Increase = -102.68%

Minimum Annual Enterprise Value = -349606.73

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025-349606.73-102.68%
202413.06M17.76%
202311.09M-24.70%
202214.73M-78.52%
202168.58M-29.69%

Chimeric Therapeutics Limited (CHMMF) Average Enterprise Value

How has CHMMF Enterprise Value performed in the past?

The current Enterprise Value of Chimeric Therapeutics Limited (CHMMF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

7.94M

5-year avg

21.42M

10-year avg

34.11M

Chimeric Therapeutics Limited (CHMMF) Enterprise Value vs. Peers

How is CHMMF’s Enterprise Value compared to its peers?

Chimeric Therapeutics Limited’s Enterprise Value is greater than Quantum Genomics S.A. (4.17M), less than Theralink Technologies, Inc. (19.38M), greater than LianBio (-40025352.00), less than Curative Biotechnology, Inc. (10.95M), less than BetterLife Pharma Inc. (9.64M), less than PharmaTher Holdings Ltd. (10.45M), greater than Tristar Wellness Solutions Inc. (4.84M), greater than NanoSphere Health Sciences Inc. (86.50K), less than Glow Lifetech Corp. (9.39M), less than ProText Mobility, Inc. (9.15M),

Build a custom stock screener for Chimeric Therapeutics Limited (CHMMF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Chimeric Therapeutics Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Chimeric Therapeutics Limited (CHMMF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Chimeric Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Chimeric Therapeutics Limited's Enterprise Value?

What is the highest Enterprise Value for Chimeric Therapeutics Limited (CHMMF)?

What is the 3-year average Enterprise Value for Chimeric Therapeutics Limited (CHMMF)?

What is the 5-year average Enterprise Value for Chimeric Therapeutics Limited (CHMMF)?

How does the current Enterprise Value for Chimeric Therapeutics Limited (CHMMF) compare to its historical average?